Cetronext 0.25mg Injection
Marketer
Lupin Ltd
Salt Composition
Cetrorelix (0.25mg)
Overview Cetronext 0.25mg Injection
Gonadex 0.25mg Injection, an antagonist of gonadotropin-releasing hormone, treats female infertility. It suppresses premature egg release, preventing ovulation. Administered subcutaneously by a healthcare professional, self-injection is contraindicated. Your doctor or nurse will instruct you on proper home injection technique. Dosage and frequency vary depending on individual needs and are determined by your physician to optimize treatment. Continue use as prescribed. Common side effects include injection site reactions (redness, itching, irritation), nausea, and vomiting. Rotate injection sites (e.g., abdomen) daily to minimize irritation. Report dizziness, fainting, abdominal pain, or persistent vomiting immediately. Before commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or if breastfeeding. Disclose all other medications being taken, as interactions may affect Gonadex's efficacy or mechanism.
Primary Ingredients of Cetronext 0.25mg Injection
The provided text is "undefined," therefore no rewriting is possible.
Uses of Cetronext 0.25mg Injection
Inability to conceive in women
Major Benefits of Cetronext 0.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cetronext 0.25mg Injection:
- Nausea
- Ovarian hyperstimulation syndrome
- Injection site reactions (pain, swelling, redness)
- Itching
- Irritation
- Vomiting
- Lower abdominal pain
How to use Cetronext 0.25mg Injection:
Administering this medication requires a healthcare professional; therefore, self-medication is strictly prohibited.
How Cetronext 0.25mg Injection works:
During infertility treatment in women, the premature expulsion of immature, unfertilizable eggs can occur. Cetronext 0.25mg Injection counteracts a natural hormone, thereby inhibiting this premature ovarian egg release.
SAFETY ADVICE
AlcoholCAUTION
It's recommended to avoid alcohol while using Cetronext 0.25mg Injection. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Cetronext 0.25mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use, given that animal and human studies indicate considerable harm to the fetus.
Breast feedingUNSAFE
Administering Cetronext 0.25mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingSAFE
Driving ability is typically unaffected by a 0.25mg Cetronext injection.
KidneyCAUTION
Patients with kidney impairment should use Cetronext 0.25mg Injection cautiously, potentially requiring dosage modification. A physician's consultation is advised. Cetronext 0.25mg Injection is contraindicated in individuals with severe kidney disease.
LiverCAUTION
Individuals with hepatic impairment should use Cetronext 0.25mg Injection cautiously; dosage modification may be necessary. Medical advice is recommended.
What if you forget to take Cetronext 0.25mg Injection :
Should you forget a dose of Cetronext 0.25mg Injection, seek your physician's advice.
Facts to Know About Cetronext 0.25mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Peptide chains |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Actions | GnRH receptor blockers |
3,018 People bought this recently